- Home
- ASIC vs NKTR Comparison
ASIC vs NKTR Comparison
Compare ASIC & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASIC
- NKTR
- Stock Information
- Founded
- ASIC 2018
- NKTR 1990
- Country
- ASIC United States
- NKTR United States
- Employees
- ASIC N/A
- NKTR N/A
- Industry
- ASIC Property-Casualty Insurers
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- ASIC Finance
- NKTR Health Care
- Exchange
- ASIC Nasdaq
- NKTR Nasdaq
- Market Cap
- ASIC 1.1B
- NKTR 1.2B
- IPO Year
- ASIC 2025
- NKTR 1994
- Fundamental
- Price
- ASIC $18.92
- NKTR $60.27
- Analyst Decision
- ASIC Strong Buy
- NKTR Strong Buy
- Analyst Count
- ASIC 4
- NKTR 6
- Target Price
- ASIC $25.50
- NKTR $91.67
- AVG Volume (30 Days)
- ASIC 213.1K
- NKTR 928.0K
- Earning Date
- ASIC 10-22-2025
- NKTR 11-05-2025
- Dividend Yield
- ASIC N/A
- NKTR N/A
- EPS Growth
- ASIC N/A
- NKTR N/A
- EPS
- ASIC 0.17
- NKTR N/A
- Revenue
- ASIC $405,657,000.00
- NKTR $74,934,000.00
- Revenue This Year
- ASIC $16.14
- NKTR N/A
- Revenue Next Year
- ASIC $47.06
- NKTR N/A
- P/E Ratio
- ASIC $109.21
- NKTR N/A
- Revenue Growth
- ASIC 42.48
- NKTR N/A
- 52 Week Low
- ASIC $16.35
- NKTR $6.48
- 52 Week High
- ASIC $25.30
- NKTR $65.79
- Technical
- Relative Strength Index (RSI)
- ASIC N/A
- NKTR 59.77
- Support Level
- ASIC N/A
- NKTR $57.91
- Resistance Level
- ASIC N/A
- NKTR $65.79
- Average True Range (ATR)
- ASIC 0.00
- NKTR 4.39
- MACD
- ASIC 0.00
- NKTR -0.32
- Stochastic Oscillator
- ASIC 0.00
- NKTR 63.35
About ASIC Ategrity Specialty Insurance Company Holdings Common Stock
Ategrity Specialty Insurance Co Holdings Formerly Ategrity Specialty Holdings LLC is a specialty insurance company dedicated to providing excess and surplus products to small to medium-sized businesses across the United States. It offers property and casualty insurance solutions tailored to meet the needs of SMBs. The company focuses on are Real Estate, Hospitality, Construction, and Retail.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.